Hey! I’m Edo, married + 2 cats, I live in Tel-Aviv, Israel, and I feel weird writing about myself so I go meta.
I’m a mathematician, I love solving problems and helping people. My LinkedIn profile has some more stuff.
I’m a forum moderator, which mostly means that I care about this forum and about you! So let me know if there’s anything I can do to help.
I’m currently working full-time at EA Israel, doing independent research and project management. Currently mostly working on evaluating the impact of for-profit tech companies, but I have many projects and this changes rapidly.
How should we compare their (CCC’s) cost-benefit estimates to GiveWell’s (GW’s) results?
I quickly spot two differences:
GW’s benefit estimates are in units of doubling of consumption (interventions are compared to direct cash transfers through Give Directly, itself measured in terms of doubling of consumption), whereas CCC’s estimates are in units of value of a statistical life.
CCC’s analyses are for large-scale government operations, so
they don’t account for counterfactual investments,
they encounter diminishing returns (compared to GW’s focus on the marginal dollar).
Points 1. and 2.a. are both indications that CCC’s cost-benefit ratios are higher than GW-esque’s cost-effectiveness ratios, while 2.b. goes to the other direction.
From the Tuberculosis paper, regarding value of a statistical life (VSL):
In comparison, GW estimates that one can save a life (or have equivalent impact) at about $5000. That’s a factor of ~20. [I think this is misleading, so I’d be interested in a more careful comparison here, directly comparing VSL to doubling of consumption].
I’m also not sure how exactly to account for the differences in 2.